Mukka Proteins Limited Share Price & Company Info
- Market cap
- ₹731 Cras reported by NSE
- 52-week high
- ₹33.2915-SEP-2026
- 52-week low
- ₹18.2730-MAR-2026
- P/E (NSE)
- 9.86
- Face value
- ₹1.00
- Shares issued
- 30,00,00,000
- Volume
- 1,24,196₹0.32 Cr traded
- Price band
- 5%₹23.45 – ₹25.91 on 2026-11-02
- Annual volatility
- 48.72%NSE, from daily returns
- Series
- BEtrade-for-trade
- BSE group
- Tscrip code 544135
- ISIN
- INE0CG401037
- Listed on NSE
- 07-Mar-2024
About Mukka Proteins Limited
Mukka Proteins Limited is listed on the National Stock Exchange of India under the symbol MUKKA in the BE series. NSE classifies it under the basic industry Animal Feed, part of the Fast Moving Consumer Goods sector. Its shares were listed on NSE on 07-Mar-2024. Each share has a face value of ₹1.00.
In the end-of-day data for 16 November 2026 the stock closed at ₹25.70, down 2.98% on the day. NSE puts the company's market capitalisation at about ₹731 crore. Over the past 52 weeks it has traded between ₹18.27 and ₹33.29, so the last price is 40.7% above the low and 22.8% below the high.
BE is a trade-for-trade series: every buy must be taken as delivery and every sell must be delivered, so intraday trading is not allowed. Exchanges move stocks here for surveillance reasons, often because of unusual price or volume behaviour.
NSE currently lists a regulatory note for this stock: ESM-1, NSE's Enhanced Surveillance Measure for micro and small companies; at stage I every trade is settled by delivery (trade-for-trade) and a 100% margin applies. Notes like these come from the exchange's surveillance and disclosure checks and can mean higher margins, trade-for-trade settlement or limits on trading. Check the NSE quote page for the current position before trading.
NSE puts the stock's annualised volatility at 48.72%. That is well above the level of large, established companies, so double-digit swings within a month are common.
Because the share trades below ₹30, it also appears in our list of penny stocks under ₹30, which explains the extra risks that come with low-priced shares.
Mukka Proteins Limited quarterly results
In the quarter ended June 2026 (un-audited), Mukka Proteins Limited reported total income of ₹408 crore and a net profit of ₹19.41 crore, or ₹0.66 per share. That is a net margin of 4.8% on income.
Compared with the previous quarter (March 2026), income rose 24.9%.
Mukka Proteins Limited was profitable in 3 of the 3 quarters shown below, every one of them. Figures are as filed with NSE, in ₹ crore.
| Quarter ended | Total income | Profit before tax | Net profit | EPS | Status |
|---|---|---|---|---|---|
| June 2026 | 408 | 27.50 | 19.41 | 0.66 | Un-Audited |
| March 2026 | 327 | 26.61 | 18.91 | 0.64 | Audited |
| December 2025 | 564 | 23.07 | 18.76 | 0.63 | Un-Audited |
Mukka Proteins Limited shareholding pattern
At the end of September 2026, promoters and the promoter group held 73.33% of Mukka Proteins Limited, with the public holding 26.67%. The promoter stake has not changed across the 8 quarterly filings shown, from December 2024 to September 2026.
| Quarter ended | Promoter & Promoter Group (%) | Public (%) |
|---|---|---|
| September 2026 | 73.33 | 26.67 |
| June 2026 | 73.33 | 26.67 |
| March 2026 | 73.33 | 26.67 |
| December 2025 | 73.33 | 26.67 |
| September 2025 | 73.33 | 26.67 |
| June 2025 | 73.33 | 26.67 |
| March 2025 | 73.33 | 26.67 |
| December 2024 | 73.33 | 26.67 |
Mukka Proteins Limited share price performance
Over the past year the Mukka Proteins Limited share price has lost 3.38%, against a fall of 10.92% for the NIFTY 50, so it has outperformed that index by 7.54 percentage points.
Across the 5 periods in the table, the stock beat the NIFTY 50 in 3. Past returns describe what happened; they do not predict what comes next.
| Period | MUKKA | NIFTY 50 |
|---|---|---|
| 1 month | -6.51% | +1.91% |
| 3 months | +7.29% | -5.20% |
| 6 months | +1.08% | -3.94% |
| 1 year | -3.38% | -10.92% |
| 2 years | -43.63% | -5.29% |
Mukka Proteins Limited vs industry peers
NSE compares Mukka Proteins Limited with 5 other listed companies in Animal Feed. By market capitalisation it ranks 3 of 6.
Its P/E of 9.86 compares with a median of 19.45 for the other companies in the group: the market is paying considerably less for each rupee of its recent earnings.
| Company | Market cap | Price (₹) | P/E | Promoter % | Qtr income | Qtr net profit |
|---|---|---|---|---|---|---|
| GODREJAGRO | 10,646 | 553.30 | 23.83 | 67.74 | 2,269 | 184 |
| AVANTIFEED | 8,946 | 656.60 | 15.06 | 43.23 | 1,615 | 84.23 |
| MUKKA | 729 | 24.29 | 9.86 | 73.33 | 408 | 19.41 |
| WATERBASE | 171 | 41.30 | — | 0.00 | — | — |
| NARMADA | 89.30 | 11.77 | 25.14 | 50.30 | 22.55 | 0.75 |
| AJOONI | 52.20 | 2.88 | 13.14 | 26.89 | 63.76 | 0.43 |
Mukka Proteins Limited announcements, board meetings and corporate actions
Latest announcements
The most recent filings Mukka Proteins Limited has made with NSE, newest first:
- 27-Oct-2026 · Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals: Mukka Proteins Limited has informed the Exchange about US FDA Registration. (PDF)
- 09-Oct-2026 · Commencement of commercial production/operations: Mukka Proteins Limited has informed the Exchange about Commencement of commercial production/operations. (PDF)
- 09-Oct-2026 · Giving guarantees/indemnity/ becoming a surety for third party: Mukka Proteins Limited has informed the Exchange about Giving corporate guarantee, and security by the Company. (PDF)
- 07-Oct-2026 · Credit Rating: Mukka Proteins Limited has informed the Exchange about Credit Rating (PDF)
- 07-Oct-2026 · Certificate under SEBI (Depositories and Participants) Regulations, 2018: Mukka Proteins Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 (PDF)
- 06-Oct-2026 · Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals: Mukka Proteins Limited has informed the Exchange about receipt of a USDA NOP Inputs Attestation. (PDF)
- 30-Sep-2026 · Acquisition: Mukka Proteins Limited has informed the Exchange about update on Acquisition (PDF)
- 25-Sep-2026 · Trading Window: Mukka Proteins Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (PDF)
Board meetings
- 12-Aug-2026 · Financial Results/Other business matters: To consider and approve the unaudited financial results (standalone and consolidated) of the Company for the quarter and three months period ended 30th June 2026.
- 12-Jun-2026 · Fund Raising/Other business matters: To consider Fund Raising and other business matters
- 15-May-2026 · Financial Results/Fund Raising/Other business matters: To consider and approve the financial results for the period ended March 31, 2026, Fund Raising and other business matters
- 12-Feb-2026 · Financial Results/Other business matters: MUKKA : 12-Feb-2026 : The Company has informed the Exchange that a Board meeting to be held on February 10, 2026 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on February 12, 2026, To consider and approve the financial results for the period ended December 31, 2025 and other business matters
- 10-Feb-2026 · Financial Results/Other business matters: To consider and approve the financial results for the period ended December 31, 2025 and other business matters
Risk notice: low-priced and small-company shares can be illiquid, volatile and subject to manipulation, and shareholders can lose their entire investment. This page is a factual summary, not a recommendation to buy or sell Mukka Proteins Limited.
Where to find Mukka Proteins Limited's financials
Direct downloads from NSE:
- Annual report 2025-26 (PDF, 7.08 MB)
- Annual report 2024-25 (PDF, 4.01 MB)
- Annual report 2023-24 (PDF)
For full financial statements, shareholding detail and every company announcement, go to the source:
- NSE quote pageOfficial price, price band, surveillance status, shareholding pattern and corporate actions.
- Annual reports (NSE)Search “MUKKA” to download Mukka Proteins Limited's annual reports as filed with the exchange.
- Announcements and results (NSE)Search “MUKKA” for quarterly results, board meetings and other company filings.
- BSE quote page (544135)BSE price, filings, results and shareholding for the same company.
- ScreenerTen years of profit and loss, balance sheet, cash flow and key ratios.
- TradingView chartInteractive price chart with technical indicators.
- Google FinanceQuick price overview and recent news coverage.
- Yahoo FinanceHistorical prices you can download, plus summary statistics.
Other Animal Feed stocks on MCX Trends
- Narmada Agrobase Limited (NARMADA · ₹11.63)
- Ajooni Biotech Limited (AJOONI · ₹3.07)
- Waterbase Limited (WATERBASE · ₹42.85)
- Kwality Wall's (India) Limited (KWIL · ₹42.86)
- HMA Agro Industries Limited (HMAAGRO · ₹26.09)
- Coastal Corporation Limited (COASTCORP · ₹33.38)
- Kohinoor Foods Limited (KOHINOOR · ₹27.60)
- Foods & Inns Limited (FOODSIN · ₹43.92)
Frequently asked questions
What is the Mukka Proteins Limited share price?
Mukka Proteins Limited (NSE: MUKKA) closed at ₹25.70 in the end-of-day data for 16 November 2026. For a live price, use the NSE quote page or your broker, because this page is updated from end-of-day files.
Which sector does Mukka Proteins Limited belong to?
NSE classifies Mukka Proteins Limited under Animal Feed, in the Fast Moving Consumer Goods sector.
What is the 52-week high and low of MUKKA?
The 52-week high is ₹33.29 (15-SEP-2026) and the 52-week low is ₹18.27 (30-MAR-2026), according to NSE.
Is Mukka Proteins Limited a penny stock?
At ₹25.70 the share trades below ₹30, so it appears on our list of penny stocks under ₹30. A low share price on its own says nothing about whether a company is cheap or expensive; market capitalisation, debt, profits and exchange surveillance status matter far more.
What is the promoter holding in Mukka Proteins Limited?
Promoters and the promoter group held 73.33% of Mukka Proteins Limited at the end of September 2026, according to the shareholding pattern filed with NSE.
What were Mukka Proteins Limited's latest quarterly results?
For the quarter ended June 2026, Mukka Proteins Limited reported total income of ₹408 crore and a net profit of ₹19.41 crore (EPS ₹0.66).
Where can I find Mukka Proteins Limited's annual report and financial results?
Annual reports, quarterly results and other filings are published on the NSE corporate filings pages (search for MUKKA) and on BSE. Screener also lays out several years of financial statements in one place. Links to all of these are above.